The retroviral vector family: something for everyone
The DOI matches its Crossref record; 65 of the 66 references it cites were found in a registry or an index.
Abstract
After 30 years of retroviral vector research it became clear that the parental viruses can be both friend and foe. Especially human immunodeficiency virus sparked a global pandemic, but could be converted into a versatile tool for cell therapy. For all retroviral genera, the way from virus to vector was similar resulting in split-vector systems based on the separation of the genes needed for vector particle formation and transgene expression. The first gene therapy trials, although clinically effective, revealed the genotoxicity of retroviral vectors caused by insertional mutagenesis. This issue was solved using self-inactivating vectors carrying weaker cellular promoters. Further fine-tuning was able to generate inducible systems. The current toolbox also contains vectors for the generation of induced pluripotent stem cells or efficient RNA interference. More recently the application of CRISPR-Cas9-mediated gene editing led to the development of genome-wide small guide RNA libraries targeting all human genes and single lentiviral vectors for an easy delivery of Cas9.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673
MicroRNAs: Target Recognition and Regulatory Functions
Bartel, D. P. (2009) · Cell · doi:10.1016/j.cell.2009.01.002 · Cited by 20,068
Genome-scale CRISPR-Cas9 knockout screening in human cells
Shalem, O., Sanjana, N. E., Hartenian, E., Shi, X., Scott, D. A., Mikkelsen, T. S., Heckl, D., Ebert, B. L., Root, D. E., Doench, J. G., et al. (2014) · Science · doi:10.1126/science.1247005 · Cited by 5,234
Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.
Gossen, M., & Bujard, H. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.12.5547 · Cited by 4,943
In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector
Naldini, L., Blömer, U., Gallay, P., Ory, D., Mulligan, R., Gage, F. H., Verma, I. M., & Trono, D. (1996) · Science · doi:10.1126/science.272.5259.263 · Cited by 4,903
LMO2 -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1
Hacein-Bey-Abina, S., Von Kalle, C., Schmidt, M., McCormack, M. P., Wulffraat, N., Leboulch, P., Lim, A., Osborne, C. S., Pawliuk, R., Morillon, E., et al. (2003) · Science · doi:10.1126/science.1088547 · Cited by 3,587
A Third-Generation Lentivirus Vector with a Conditional Packaging System
Dull, T., Zufferey, R., Kelly, M., Mandel, R. J., Nguyen, M., Trono, D., & Naldini, L. (1998) · Journal of Virology · doi:10.1128/jvi.72.11.8463-8471.1998 · Cited by 3,341
Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo
Zufferey, R., Nagy, D., Mandel, R. J., Naldini, L., & Trono, D. (1997) · Nature Biotechnology · doi:10.1038/nbt0997-871 · Cited by 1,977
A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency
Hacein-Bey-Abina, S., von Kalle, C., Schmidt, M., Le Deist, F., Wulffraat, N., McIntyre, E., Radford, I., Villeval, J.-L., Fraser, C. C., Cavazzana-Calvo, M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejm200301163480314 · Cited by 1,867
A Lentiviral RNAi Library for Human and Mouse Genes Applied to an Arrayed Viral High-Content Screen
Moffat, J., Grueneberg, D. A., Yang, X., Kim, S. Y., Kloepfer, A. M., Hinkle, G., Piqani, B., Eisenhaure, T. M., Luo, B., Grenier, J. K., et al. (2006) · Cell · doi:10.1016/j.cell.2006.01.040 · Cited by 1,798
Ott, M. G., Schmidt, M., Schwarzwaelder, K., Stein, S., Siler, U., Koehl, U., Glimm, H., Kühlcke, K., Schilz, A., Kunkel, H., et al. (2006) · Nature Medicine · doi:10.1038/nm1393 · Cited by 1,051
Lentiviral Hematopoietic Stem Cell Gene Therapy in Patients with Wiskott-Aldrich Syndrome
Aiuti, A., Biasco, L., Scaramuzza, S., Ferrua, F., Cicalese, M. P., Baricordi, C., Dionisio, F., Calabria, A., Giannelli, S., Castiello, M. C., et al. (2013) · Science · doi:10.1126/science.1233151 · Cited by 1,025
Zufferey, R., Donello, J. E., Trono, D., & Hope, T. J. (1999) · Journal of Virology · doi:10.1128/jvi.73.4.2886-2892.1999 · Cited by 1,014
Retroviral DNA Integration: ASLV, HIV, and MLV Show Distinct Target Site Preferences
Mitchell, R. S., Beitzel, B. F., Schroder, A. R. W., Shinn, P., Chen, H., Berry, C. C., Ecker, J. R., & Bushman, F. D. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020234 · Cited by 976
BCL11A enhancer dissection by Cas9-mediated in situ saturating mutagenesis
Canver, M. C., Smith, E. C., Sher, F., Pinello, L., Sanjana, N. E., Shalem, O., Chen, D. D., Schupp, P. G., Vinjamur, D. S., Garcia, S. P., et al. (2015) · Nature · doi:10.1038/nature15521 · Cited by 886
Site-specific integration by adeno-associated virus.
Kotin, R. M., Siniscalco, M., Samulski, R. J., Zhu, X. D., Hunter, L., Laughlin, C. A., McLaughlin, S., Muzyczka, N., Rocchi, M., & Berns, K. I. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.6.2211 · Cited by 868
Lombardo, A., Genovese, P., Beausejour, C. M., Colleoni, S., Lee, Y.-L., Kim, K. A., Ando, D., Urnov, F. D., Galli, C., Gregory, P. D., et al. (2007) · Nature Biotechnology · doi:10.1038/nbt1353 · Cited by 845
HIV-1 Genome Nuclear Import Is Mediated by a Central DNA Flap
Zennou, V., Petit, C., Guetard, D., Nerhbass, U., Montagnier, L., & Charneau, P. (2000) · Cell · doi:10.1016/s0092-8674(00)80828-4 · Cited by 833
Site-specific integration by adeno-associated virus.
Linden, R. M., Ward, P., Giraud, C., Winocour, E., & Berns, K. I. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.21.11288 · Cited by 805
Targeted integration of adeno-associated virus (AAV) into human chromosome 19.
Samulski, R. J., Zhu, X., Xiao, X., Brook, J. D., Housman, D. E., Epstein, N., & Hunter, L. A. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb04964.x · Cited by 784
Viruses, microRNAs, and Host Interactions
Skalsky, R. L., & Cullen, B. R. (2010) · Annual Review of Microbiology · doi:10.1146/annurev.micro.112408.134243 · Cited by 676
KRAB-containing zinc-finger repressor proteins.
Urrutia, R. A. (2003) · Genome biology · doi:10.1186/gb-2003-4-10-231 · Cited by 595
Posey, A. D., Schwab, R. D., Boesteanu, A. C., Steentoft, C., Mandel, U., Engels, B., Stone, J. D., Madsen, T. D., Schreiber, K., Haines, K. M., et al. (2016) · Immunity · doi:10.1016/j.immuni.2016.05.014 · Cited by 594
Form and Function of Retroviral Proviruses
Varmus, H. E. (1982) · Science · doi:10.1126/science.6177038 · Cited by 583
Montini, E., Cesana, D., Schmidt, M., Sanvito, F., Bartholomae, C. C., Ranzani, M., Benedicenti, F., Sergi, L. S., Ambrosi, A., Ponzoni, M., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37630 · Cited by 571
Heckl, D., Kowalczyk, M. S., Yudovich, D., Belizaire, R., Puram, R. V., McConkey, M. E., Thielke, A., Aster, J. C., Regev, A., & Ebert, B. L. (2014) · Nature Biotechnology · doi:10.1038/nbt.2951 · Cited by 555
Self-inactivating retroviral vectors designed for transfer of whole genes into mammalian cells.
Yu, S. F., von Rüden, T., Kantoff, P. W., Garber, C., Seiberg, M., Rüther, U., Anderson, W. F., Wagner, E. F., & Gilboa, E. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.10.3194 · Cited by 541
Tiscornia, G., Singer, O., Ikawa, M., & Verma, I. M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0437912100 · Cited by 540
Reprogramming of murine and human somatic cells using a single polycistronic vector
Carey, B. W., Markoulaki, S., Hanna, J., Saha, K., Gao, Q., Mitalipova, M., & Jaenisch, R. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0811426106 · Cited by 503
Brown, B. D., Venneri, M. A., Zingale, A., Sergi, L. S., & Naldini, L. (2006) · Nature Medicine · doi:10.1038/nm1398 · Cited by 484
A Modified γ-Retrovirus Vector for X-Linked Severe Combined Immunodeficiency
Hacein-Bey-Abina, S., Pai, S.-Y., Gaspar, H. B., Armant, M., Berry, C. C., Blanche, S., Bleesing, J., Blondeau, J., de Boer, H., Buckland, K. F., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1404588 · Cited by 412
Flint, S. J. (2008) · Cited by 365
TRIM28 Mediates Primer Binding Site-Targeted Silencing of Murine Leukemia Virus in Embryonic Cells
Wolf, D., & Goff, S. P. (2007) · Cell · doi:10.1016/j.cell.2007.07.026 · Cited by 342
Kobinger, G. P., Weiner, D. J., Yu, Q.-C., & Wilson, J. M. (2001) · Nature Biotechnology · doi:10.1038/85664 · Cited by 307
Stable knockdown of microRNA in vivo by lentiviral vectors
Gentner, B., Schira, G., Giustacchini, A., Amendola, M., Brown, B. D., Ponzoni, M., & Naldini, L. (2009) · Nature Methods · doi:10.1038/nmeth.1277 · Cited by 304
Cell culture assays reveal the importance of retroviral vector design for insertional genotoxicity
Modlich, U., Bohne, J., Schmidt, M., von Kalle, C., Knöss, S., Schambach, A., & Baum, C. (2006) · Blood · doi:10.1182/blood-2005-08-024976 · Cited by 278
Self-citationWarlich, E., Kuehle, J., Cantz, T., Brugman, M. H., Maetzig, T., Galla, M., Filipczyk, A. A., Halle, S., Klump, H., Schöler, H. R., et al. (2011) · Molecular Therapy · doi:10.1038/mt.2010.314 · Cited by 259
Improved Tet-responsive promoters with minimized background expression
Loew, R., Heinz, N., Hampf, M., Bujard, H., & Gossen, M. (2010) · BMC Biotechnology · doi:10.1186/1472-6750-10-81 · Cited by 246
Embryonic stem cell virus, a recombinant murine retrovirus with expression in embryonic stem cells.
Grez, M., Akgün, E., Hilberg, F., & Ostertag, W. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.23.9202 · Cited by 197
Devroe, E., & Silver, P. A. (2002) · BMC Biotechnology · doi:10.1186/1472-6750-2-15 · Cited by 184
Genome-Wide Analyses of Avian Sarcoma Virus Integration Sites
Narezkina, A., Taganov, K. D., Litwin, S., Stoyanova, R., Hayashi, J., Seeger, C., Skalka, A. M., & Katz, R. A. (2004) · Journal of Virology · doi:10.1128/jvi.78.21.11656-11663.2004 · Cited by 161
Schambach, A., Mueller, D., Galla, M., Verstegen, M. M. A., Wagemaker, G., Loew, R., Baum, C., & Bohne, J. (2006) · Gene Therapy · doi:10.1038/sj.gt.3302807 · Cited by 148
Self-citationRepurposing CRISPR/Cas9 for in situ functional assays
Malina, A., Mills, J. R., Cencic, R., Yan, Y., Fraser, J., Schippers, L. M., Paquet, M., Dostie, J., & Pelletier, J. (2013) · Genes & Development · doi:10.1101/gad.227132.113 · Cited by 133
Genome editing at the crossroads of delivery, specificity, and fidelity
Maggio, I., & Gonçalves, M. A. F. V. (2015) · Trends in Biotechnology · doi:10.1016/j.tibtech.2015.02.011 · Cited by 132
Progress and Prospects: Gene Therapy Clinical Trials (Part 1)
Alton, E. W. F. W. (2007) · Gene Therapy · doi:10.1038/sj.gt.3303001 · Cited by 132
Lentiviral vectors, two decades later
Naldini, L., Trono, D., & Verma, I. M. (2016) · Science · doi:10.1126/science.aah6192 · Cited by 123
cis-Acting RNA packaging locus in the 115-nucleotide direct repeat of Rous sarcoma virus
Sorge, J., Ricci, W., & Hughes, S. H. (1983) · Journal of Virology · doi:10.1128/jvi.48.3.667-675.1983 · Cited by 115
Koponen, J., Kankkonen, H. M., Kannasto, J., Wirth, T., Hillen, W., Bujard, H., & Ylä‐Herttuala, S. (2003) · Gene Therapy · doi:10.1038/sj.gt.3301889 · Cited by 113
Avian retroviral RNA element promotes unspliced RNA accumulation in the cytoplasm
Ogert, R. A., Lee, L. H., & Beemon, K. L. (1996) · Journal of Virology · doi:10.1128/jvi.70.6.3834-3843.1996 · Cited by 110
Two decades of clinical gene therapy--success is finally mounting.
Herzog, R. W., Cao, O., & Srivastava, A. (2010) · PubMed · Cited by 102
Heinz, N., Schambach, A., Galla, M., Maetzig, T., Baum, C., Loew, R., & Schiedlmeier, B. (2011) · Human Gene Therapy · doi:10.1089/hum.2010.099 · Cited by 96
Foamy Virus Biology and Its Application for Vector Development
Lindemann, D., & Rethwilm, A. (2011) · Viruses · doi:10.3390/v3050561 · Cited by 95
Self-Inactivating Alpharetroviral Vectors with a Split-Packaging Design
Suerth, J. D., Maetzig, T., Galla, M., Baum, C., & Schambach, A. (2010) · Journal of Virology · doi:10.1128/jvi.00182-10 · Cited by 88
Modifying the host range properties of retroviral vectors
Russell, S. J., & Cosset, F.-L. (1999) · The Journal of Gene Medicine · doi:10.1002/(sici)1521-2254(199909/10)1:5<300::aid-jgm59>3.0.co;2-t · Cited by 84
Suerth, J. D., Maetzig, T., Brugman, M. H., Heinz, N., Appelt, J.-U., Kaufmann, K. B., Schmidt, M., Grez, M., Modlich, U., Baum, C., et al. (2012) · Molecular Therapy · doi:10.1038/mt.2011.309 · Cited by 73
Vigna, E., Amendola, M., Benedicenti, F., Simmons, A. D., Follenzi, A., & Naldini, L. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2004.11.017 · Cited by 60
Vieyra, D. S., & Goodell, M. A. (2007) · Stem Cells · doi:10.1634/stemcells.2007-0248 · Cited by 41
Furger, A., Monks, J., & Proudfoot, N. J. (2001) · Journal of Virology · doi:10.1128/jvi.75.23.11735-11746.2001 · Cited by 40
Wodrich, H., Bohne, J., Gumz, E., Welker, R., & Kräusslich, H.-G. (2001) · Journal of Virology · doi:10.1128/jvi.75.22.10670-10682.2001 · Cited by 39
Self-citationExploiting microRNA regulation for genetic engineering
Gentner, B., & Naldini, L. (2012) · Tissue Antigens · doi:10.1111/tan.12002 · Cited by 35
Glimm, H. (2005) · Blood · doi:10.1182/blood-2004-07-2859 · Cited by 31
Kuehle, J., Turan, S., Cantz, T., Hoffmann, D., Suerth, J. D., Maetzig, T., Zychlinski, D., Klein, C., Steinemann, D., Baum, C., et al. (2014) · Molecular Therapy · doi:10.1038/mt.2014.4 · Cited by 23
Schott, J. W., Hoffmann, D., Maetzig, T., Müller, F.-J., Steinemann, D., Zychlinski, D., Cantz, T., Baum, C., & Schambach, A. (2014) · Gene Therapy · doi:10.1038/gt.2014.69 · Cited by 12
Mutagenesis of the Mouse Germline Using Retroviruses
Lock, L. F., Jenkins, N. A., & Copeland, N. G. (1991) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-76524-7_2 · Cited by 7
Lachmann, N., Brennig, S., Hillje, R., Schermeier, H., Phaltane, R., Dahlmann, J., Gruh, I., Heinz, N., Schiedlmeier, B., Baum, C., et al. (2015) · Gene Therapy · doi:10.1038/gt.2015.61 · Cited by 7
Research works printed but not linked: 3
- R.W. Herzog, O. Cao, A. Srivastava, Discov. Med. 9, 105–111 (2010)
- J.M. Coffin, S.H. Hughes, H.E. Varmus, Retroviruses (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, 1997)
- L.F. Lock, N.A. Jenkins, N.G. Copeland, Curr. Top. Microbiol. Immunol. 171, 27–41 (1991)
Cited by
The approved gene therapy drugs worldwide: from 1998 to 2019
Ma, C.-C., Wang, Z.-L., Xu, T., He, Z.-Y., & Wei, Y.-Q. (2020) · Biotechnology Advances · doi:10.1016/j.biotechadv.2019.107502 · Cited by 310
HEK293 Cell Line as a Platform to Produce Recombinant Proteins and Viral Vectors
Tan, E., Chin, C. S. H., Lim, Z. F. S., & Ng, S. K. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.796991 · Cited by 251
“In this family of viruses, γ-retroviruses (γRV) based on the Murine Leukemia Virus and lentiviruses (LV) based on the Human Immunodeficiency Virus type 1, are commonly used in gene therapies (Elsner and Bohne, 2017; Milone and O’Doherty, 2018).”
BackgroundMethodEngineering siRNA therapeutics: challenges and strategies
Ali Zaidi, S. S., Fatima, F., Ali Zaidi, S. A., Zhou, D., Deng, W., & Liu, S. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-02147-z · Cited by 242
“This deletion inactivates the promoter and enhancer elements in the 3’ LTR, reducing the risk of insertional mutagenesis [84, 85].”
BackgroundAn Overview of Methods and Tools for Transfection of Eukaryotic Cells in vitro
Fus-Kujawa, A., Prus, P., Bajdak-Rusinek, K., Teper, P., Gawron, K., Kowalczuk, A., & Sieron, A. L. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.701031 · Cited by 186
Viral Vectors for Gene Transfer
Chen, Y. H., Keiser, M. S., & Davidson, B. L. (2018) · Current Protocols in Mouse Biology · doi:10.1002/cpmo.58 · Cited by 146
“Furthermore, tat is eliminated through the addition of a chimeric 5 LTR fused to a heterologous promoter on the vector plasmid (Elsner & Bohne, 2017).”
Metadata
- Authors
- Elsner, C., & Bohne, J.
- Affiliations
- Medizinische Hochschule Hannover (DE)
- Corresponding author
- Bohne, Jens
- Venue
- Virus Genes
- Published
- 2017-07-31
- Volume
- 53
- Issue
- 5
- Pages
- 714-722
- ISSN
- 0920-8569 (ISSN-L)
- 1572-994X
- OpenAlex
- W2739710942
- Cited by
- 36
- References
- 66
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 8 · 2023: 4 · 2022: 3 · 2021: 7 · 2020: 4 · 2019: 3 · 2018: 4 · 2017: 1
- FWCI
- 0.42
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Virus Genes (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Else Kröner-Fresenius-Stiftung (2014_A88)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Keywords
- retroviral vectors, lentiviral vectors, self-inactivating vectors, insertional mutagenesis, genotoxicity, inducible gene expression, induced pluripotent stem cells, RNA interference, CRISPR/Cas9, guide RNA library, cell therapy
- MeSH terms
- Animals, Genetic Vectors, Humans, Promoter Regions, Genetic, Retroviridae, Genetic Therapy, Lentivirus, Transgenes, RNA Interference
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.